Consistently, increased NF-kB activation signals in skin keratinocytes and immune cells in AD patients are significantly stronger than those in PV patients and healthy controls (61), which indicates increased HMGB1/NF-κB pathway activity in the skin of patients with AD. This evidence concerns the gene NFKB1 and Alzheimer disease.